Intensity-modulated radiation therapy for nasopharyngeal carcinoma: a review

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Radiation Oncology

• Publication date

  2012-05-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13566-012-0020-4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial.

  2012cited by this paper
• Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma

  2012influential reference
• A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma.

  2012influential reference
• Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.

  2012cited by this paper
• Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.

  2011cited by this paper
• Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

  2011cited by this paper
• Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy

  2011cited by this paper
• Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial.

  2011cited by this paper
• Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma.

  2011influential reference
• Use of normal tissue complication probability models in the clinic.

  2010cited by this paper
• Controversies and challenges in the current management of nasopharyngeal cancer

  2010cited by this paper
• Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.

  2010influential reference
• Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: Experience of 370 consecutive cases

  2010influential reference
• Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.

  2010cited by this paper
• Long-term treatment outcome of nasopharyngeal carcinoma (NPC) using intensity-modulated radiotherapy (IMRT).

  2010cited by this paper
• Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.

  2009influential reference
• Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225.

  2009influential reference
• Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience.

  2008influential reference
• How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography?

  2008cited by this paper
• Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.

  2008cited by this paper
• Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.

  2007cited by this paper
• Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma.

  2006influential reference
• Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma.

  2006cited by this paper
• Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

  2006cited by this paper
• Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience.

  2006influential reference
• Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.

  2006cited by this paper
• Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results.

  2005cited by this paper
• Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety.

  2005cited by this paper
• Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.

  2005cited by this paper
• Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group.

  2005cited by this paper
• Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience.

  2005cited by this paper
• Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma.

  2005cited by this paper
• Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.

  2004influential reference
• Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy

  2004cited by this paper
• Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study.

  2004cited by this paper
• Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.

  2003cited by this paper
• CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.

  2003cited by this paper
• Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review.

  2003cited by this paper
• Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival.

  2003cited by this paper
• AJCC Cancer Staging Manual. 6th ed

  2002cited by this paper
• Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial.

  2002cited by this paper
• Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer.

  2002cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• Quality of life and oral function in patients treated with radiation therapy for head and neck cancer

  2001cited by this paper
• Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.

  2001influential reference
• Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer.

  2001cited by this paper
• Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma.

  2000cited by this paper
• Dysphagia after Radiotherapy: Endoscopic Examination of Swallowing in Patients with Nasopharyngeal Carcinoma

  2000cited by this paper
• Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality.

  2000cited by this paper
• Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers.

  2000cited by this paper
• Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy

  1999cited by this paper
• Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.

  1999cited by this paper
• Quality of life and oral function following radiotherapy for head and neck cancer

  1999cited by this paper
• Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.

  1999cited by this paper
• Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

  1998cited by this paper
• Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control.

  1997cited by this paper
• Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival.

  1997cited by this paper
• Concurrent cisplatin, infusional fluorouracil, and conventionally fractionated radiation therapy in head and neck cancer: dose-limiting mucosal toxicity.

  1991cited by this paper
• Nasopharyngeal cancer: study III. A review of 1206 patients treated with combined modalities.

  1985cited by this paper
• Nasopharyngeal cancer: study II.

  1981cited by this paper

• A Decision-Making Method for Photon/Proton Selection for Nasopharyngeal Cancer Based on Dose Prediction and NTCP

  2025cites this paper
• Locally advanced nasopharyngeal carcinoma in adolescents treated with tomotherapy: Experience at King Faisal Specialist Hospital and Research Centre

  2024cites this paper
• Worsening Rhinosinusitis as a Prognostic Factor for Patients with Nasopharyngeal Carcinoma: A Retrospective Study

  2022influential citation
• Dihydromyricetin inhibits cancer cell migration and matrix metalloproteinases‐2 expression in human nasopharyngeal carcinoma through extracellular signal‐regulated kinase signaling pathway

  2022cites this paper
• Variations of Clinical Target Volume Delineation for Primary Site of Nasopharyngeal Cancer Among Five Centers in China

  2020cites this paper
• Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients

  2020cites this paper
• A Prospective 10-year Observational Study of Reduction of Radiotherapy Clinical Target Volume and Dose in Early-stage Nasopharyngeal Carcinoma.

  2020cites this paper
• Constructing Novel Prognostic Biomarkers of Advanced Nasopharyngeal Carcinoma from Multiparametric MRI Radiomics Using Ensemble-Model Based Iterative Feature Selection

  2019cites this paper
• Nasopharyngeal Carcınoma in Chıldren and Adolescents; Experıence of EGE Unıversıty from Turkey

  2019cites this paper
• Neck stiffness in a post-irradiated nasopharyngeal carcinoma adult: An unusual diagnosis.

  2019cites this paper
• Dosimetric Comparisons of Volumetric Modulated Arc Therapy and Tomotherapy for Early T-Stage Nasopharyngeal Carcinoma

  2018cites this paper
• Long‐term outcomes after reirradiation in nasopharyngeal carcinoma with intensity‐modulated radiotherapy: A meta‐analysis

  2018cites this paper
• Intensity‐modulated radiotherapy for elderly patients with nasopharyngeal carcinoma

  2018influential citation
• High-Dose Static and Dynamic Intensity-Modulated Radiotherapy Combined with Chemotherapy for Patients with Locally Advanced Nasopharyngeal Carcinoma Improves Survival and Reduces Brainstem Toxicity

  2018cites this paper
• Locoregional extension and patterns of failure for nasopharyngeal carcinoma with intracranial extension.

  2018cites this paper
• Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results

  2018cites this paper
• Predicting xerostomia after IMRT treatments: a data mining approach

  2018cites this paper
• Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy

  2018cites this paper
• Combined chemoradiation vs radiation therapy alone in stage-II nasopharyngeal carcinoma: A meta-analysis of the published literature.

  2018cites this paper
• Chemoradiotherapy Versus Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: A Systemic Review and Meta-analysis of 2138 Patients

  2017cites this paper
• Identification of potentially critical differentially methylated genes in nasopharyngeal carcinoma: A comprehensive analysis of methylation profiling and gene expression profiling

  2017cites this paper
• Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era

  2017cites this paper
• Predicting xerostomia after IMRT treatments: a data mining approach

  2017cites this paper
• Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials

  2017cites this paper
• International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma.

  2017cites this paper
• Clinicopathological significance of ROCK1 and PIK3CA expression in nasopharyngeal carcinoma.

  2017cites this paper
• A new T staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results from a prospective multicentric clinical study.

  2017influential citation
• Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma

  2016cites this paper
• Locoregionally advanced nasopharyngeal carcinoma in childhood and adolescence: Analysis of 95 patients treated with combined chemotherapy and intensity‐modulated radiotherapy

  2016influential citation
• Intensity‐modulated radiotherapy for head and neck surgeons

  2016cites this paper
• Upregulation of KLHDC4 Predicts a Poor Prognosis in Human Nasopharyngeal Carcinoma

  2016cites this paper
• Salvage Intensity-Modulated Radiation Therapy (IMRT) for Locally Recurrent Nasopharyngeal Cancer after Definitive IMRT: A Novel Scenario of the Modern Era

  2016cites this paper
• Long-Term Outcomes of Nasopharyngeal Carcinoma in 148 Children and Adolescents

  2016cites this paper
• Prognostic Evaluation of Nasopharyngeal Carcinoma with Bone-Only Metastasis after Therapy

  2016cites this paper
• Pediatric Nasopharyngeal Cancer: Case Report and Review of the Literature

  2016cites this paper
• Leakage-Penumbra effect in intensity modulated radiation therapy step-and-shoot dose delivery.

  2016cites this paper
• Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma.

  2016cites this paper
• Long-term survival of nasopharyngeal carcinoma patients with Stage II in intensity-modulated radiation therapy era.

  2016cites this paper
• [Radiotherapy for nasopharyngeal carcinoma].

  2016cites this paper
• adiothérapie des cancers du nasopharynx adiotherapy for nasopharyngeal carcinoma

  2016cites this paper
• Update report of T4 classification nasopharyngeal carcinoma after intensity-modulated radiotherapy: an analysis of survival and treatment toxicities.

  2015cites this paper
• Radiotherapy for Head and Neck Cancer in Lombardy: A Survey by the Lombardy Group of the Italian Association for Radiation Oncology

  2015cites this paper
• Concurrent Chemotherapy for T4 Classification Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy

  2015cites this paper
• The dosimetric comparison of the radiotherapeutic plans between composite and synchronous planning approaches in sequential IMRT for nasopharyngeal carcinoma.

  2015cites this paper
• Suggestions for Lymph Node Classification of UICC/AJCC Staging System: A Retrospective Study Based on 1197 Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiation Therapy

  2015cites this paper
• The Correlation Between the Comprehensive Nutrition Index and Quality of Life of Patients with Nasopharyngeal Carcinoma Treated by Intensity-Modulated Radiotherapy

  2014cites this paper
• Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas

  2014cites this paper
• Management of the node-negative neck in early-stage nasopharyngeal carcinoma

  2014cites this paper
• Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma

  2014cites this paper
• Nasopharyngeal Carcinoma: Management Strategies

  2014cites this paper
• Radioluminescence characterization of in situ x-ray nanodosimeters: Potential real-time monitors and modulators of external beam radiation therapy.

  2014cites this paper
• Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin.

  2014cites this paper
• Addition of intracavitary brachytherapy to external beam radiation therapy for T1-T2 nasopharyngeal carcinoma.

  2013cites this paper
• Effect of intensity-modulated versus conventional radiotherapy on quality of life in patients with nasopharyngeal cancer: a cross-sectional study

  2013cites this paper
• Experience with combination of cetuximab plus intensity-modulated radiotherapy with or without chemotherapy for locoregionally advanced nasopharyngeal carcinoma

  2013cites this paper
• Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma

  2013cites this paper
• Report on revision of the Chinese 1992 staging system for nasopharyngeal carcinoma

  2013cites this paper
• A randomized clinical trial comparing prophylactic upper versus whole‐neck irradiation in the treatment of patients with node‐negative nasopharyngeal carcinoma

  2013cites this paper
• Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue

  2013cites this paper
• Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma.

  2013cites this paper
• Emerging treatment options for nasopharyngeal carcinoma

  2013cites this paper
• Radiation therapy for locoregionally advanced nasopharyngeal carcinoma in elderly patients

  2012cites this paper
• Prognostic signifi cance of pre-treatment latent membrane protein 1 from nasopharyngeal swabs for stage III – IVA nasopharyngeal carcinoma

  2012cites this paper